236 related articles for article (PubMed ID: 33959010)
1. Berberine Regulated miR150-5p to Inhibit P2X7 Receptor, EMMPRIN and MMP-9 Expression in oxLDL Induced Macrophages.
Lu L; Huang J; Xue X; Wang T; Huang Z; Li J
Front Pharmacol; 2021; 12():639558. PubMed ID: 33959010
[TBL] [Abstract][Full Text] [Related]
2. Curcumin Alleviates oxLDL Induced MMP-9 and EMMPRIN Expression through the Inhibition of NF-κB and MAPK Pathways in Macrophages.
Cao J; Ye B; Lin L; Tian L; Yang H; Wang C; Huang W; Huang Z
Front Pharmacol; 2017; 8():62. PubMed ID: 28261097
[TBL] [Abstract][Full Text] [Related]
3. P2X7 receptor regulates EMMPRIN and MMP‑9 expression through AMPK/MAPK signaling in PMA‑induced macrophages.
Lin L; Huang S; Zhu Z; Han J; Wang Z; Huang W; Huang Z
Mol Med Rep; 2018 Sep; 18(3):3027-3033. PubMed ID: 30015874
[TBL] [Abstract][Full Text] [Related]
4. Suppression of oxLDL-induced MMP-9 and EMMPRIN expression by berberine via inhibition of NF-κB activation in human THP-1 macrophages.
Huang Z; Meng S; Wang L; Wang Y; Chen T; Wang C
Anat Rec (Hoboken); 2012 Jan; 295(1):78-86. PubMed ID: 22140092
[TBL] [Abstract][Full Text] [Related]
5. Artemisinin inhibits extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase-9 expression via a protein kinase Cδ/p38/extracellular signal-regulated kinase pathway in phorbol myristate acetate-induced THP-1 macrophages.
Wang Y; Huang ZQ; Wang CQ; Wang LS; Meng S; Zhang YC; Chen T; Fan YQ
Clin Exp Pharmacol Physiol; 2011 Jan; 38(1):11-8. PubMed ID: 21039753
[TBL] [Abstract][Full Text] [Related]
6. Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages.
Cao J; Han Z; Tian L; Chen K; Fan Y; Ye B; Huang W; Wang C; Huang Z
J Transl Med; 2014 Sep; 12():266. PubMed ID: 25241044
[TBL] [Abstract][Full Text] [Related]
7. Berberine reduces both MMP-9 and EMMPRIN expression through prevention of p38 pathway activation in PMA-induced macrophages.
Huang Z; Wang L; Meng S; Wang Y; Chen T; Wang C
Int J Cardiol; 2011 Jan; 146(2):153-8. PubMed ID: 19576641
[TBL] [Abstract][Full Text] [Related]
8. Visfatin/PBEF/Nampt induces EMMPRIN and MMP-9 production in macrophages via the NAMPT-MAPK (p38, ERK1/2)-NF-κB signaling pathway.
Fan Y; Meng S; Wang Y; Cao J; Wang C
Int J Mol Med; 2011 Apr; 27(4):607-15. PubMed ID: 21327328
[TBL] [Abstract][Full Text] [Related]
9. Oxidized low-density lipoproteins stimulate extracellular matrix metalloproteinase Inducer (EMMPRIN) release by coronary smooth muscle cells.
Haug C; Lenz C; Díaz F; Bachem MG
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1823-9. PubMed ID: 15319264
[TBL] [Abstract][Full Text] [Related]
10. The feedback loop of "EMMPRIN/NF-κB" worsens atherosclerotic plaque via suppressing autophagy in macrophage.
Liang X; Hou X; Yang Y; Liu H; Guo R; Yang Z; Yang L
J Mol Cell Cardiol; 2018 Jan; 114():129-140. PubMed ID: 29154780
[TBL] [Abstract][Full Text] [Related]
11. Iron deficiency activates pro-inflammatory signaling in macrophages and foam cells via the p38 MAPK-NF-κB pathway.
Fan Y; Wang J; Wei L; He B; Wang C; Wang B
Int J Cardiol; 2011 Oct; 152(1):49-55. PubMed ID: 20674992
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of EMMPRIN and MMP-9 Expression by Epigallocatechin-3-Gallate through 67-kDa Laminin Receptor in PMA-Induced Macrophages.
Wang QM; Wang H; Li YF; Xie ZY; Ma Y; Yan JJ; Gao YF; Wang ZM; Wang LS
Cell Physiol Biochem; 2016; 39(6):2308-2319. PubMed ID: 27832636
[TBL] [Abstract][Full Text] [Related]
13. Ellagic acid inhibits oxidized low-density lipoprotein (OxLDL)-induced metalloproteinase (MMP) expression by modulating the protein kinase C-α/extracellular signal-regulated kinase/peroxisome proliferator-activated receptor γ/nuclear factor-κB (PKC-α/ERK/PPAR-γ/NF-κB) signaling pathway in endothelial cells.
Kuo MY; Ou HC; Lee WJ; Kuo WW; Hwang LL; Song TY; Huang CY; Chiu TH; Tsai KL; Tsai CS; Sheu WH
J Agric Food Chem; 2011 May; 59(9):5100-8. PubMed ID: 21480623
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinases (MMP), EMMPRIN (extracellular matrix metalloproteinase inducer) and mitogen-activated protein kinases (MAPK): co-expression in metastatic serous ovarian carcinoma.
Davidson B; Givant-Horwitz V; Lazarovici P; Risberg B; Nesland JM; Trope CG; Schaefer E; Reich R
Clin Exp Metastasis; 2003; 20(7):621-31. PubMed ID: 14669793
[TBL] [Abstract][Full Text] [Related]
15. Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cells.
Tsai KL; Chang YL; Huang PH; Cheng YH; Liu DH; Chen HY; Kao CL
J Vasc Surg; 2016 Jan; 63(1):204-15.e1. PubMed ID: 25080882
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of PPAR on the expression of EMMPRIN in macrophages and foam cells.
Zhang J; Ge H; Wang C; Guo TB; He Q; Shao Q; Fan Y
Int J Cardiol; 2007 May; 117(3):373-80. PubMed ID: 16860414
[TBL] [Abstract][Full Text] [Related]
17. Resveratrol inhibits EMMPRIN expression via P38 and ERK1/2 pathways in PMA-induced THP-1 cells.
Huang Z; Wang C; Wei L; Wang J; Fan Y; Wang L; Wang Y; Chen T
Biochem Biophys Res Commun; 2008 Sep; 374(3):517-21. PubMed ID: 18647594
[TBL] [Abstract][Full Text] [Related]
18. MMP-9 inhibition by ACE inhibitor reduces oxidized LDL-mediated foam-cell formation.
Kojima C; Ino J; Ishii H; Nitta K; Yoshida M
J Atheroscler Thromb; 2010 Feb; 17(1):97-105. PubMed ID: 20093780
[TBL] [Abstract][Full Text] [Related]
19. Oxidized low-density lipoprotein induces matrix metalloproteinase-9 expression via a p42/p44 and JNK-dependent AP-1 pathway in brain astrocytes.
Wang HH; Hsieh HL; Wu CY; Sun CC; Yang CM
Glia; 2009 Jan; 57(1):24-38. PubMed ID: 18661553
[TBL] [Abstract][Full Text] [Related]
20. NOS3 prevents MMP-9, and MMP-13 induced extracellular matrix proteolytic degradation through specific microRNA-targeted expression of extracellular matrix metalloproteinase inducer in hypertension-related atherosclerosis.
Ramírez-Carracedo R; Hernández I; Moreno-Gómez-Toledano R; Díez-Mata J; Tesoro L; González-Cucharero C; Jiménez-Guirado B; Alcharani N; Botana L; Saura M; Zamorano JL; Zaragoza C
J Hypertens; 2024 Apr; 42(4):685-693. PubMed ID: 38406874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
